Topical 2% Lidocaine for the Treatment of Symptomatic Hemorrhoids
Status:
Unknown status
Trial end date:
2014-03-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate the efficacy of topical 2% lidocaine in
the therapy of symptomatic hemorrhoids. Efficacy will be determined by:
1. the change from baseline in pain, itching, bleeding, swelling, discomfort, general
well-being and improvement since the beginning of treatment as separate components of
CORRECTS scale
2. the change in overall CORRECTS values from baseline
3. the change in degree of hemorrhoids from baseline